Fundz

Intensity Therapeutics Appoints Joseph Talamo, CPA, as Chief Financial Officer

PUBLIC · INTSDec 12, 2023

Position

Chief Financial Officer

Company

Intensity Therapeutics

Joseph Talamo
jtalamo@intensitytherapeutics.com
SheltonManufacturingBiotechnologyHealth CareTherapeutics

Description

Intensity Therapeutics, Inc. , a clinical-stage biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition of cancers, today announced the appointment of Joseph Talamo as Chief Financial Officer

Quick answer

Intensity Therapeutics Appoints Joseph Talamo, CPA, as Chief Financial Officer (December 12, 2023). Intensity Therapeutics is based in Shelton, Connecticut, United States.

Who is the new Chief Financial Officer at Intensity Therapeutics?
Intensity Therapeutics named Joseph Talamo Chief Financial Officer, announced December 12, 2023.
What did Intensity Therapeutics announce on December 12, 2023?
Intensity Therapeutics, Inc. , a clinical-stage biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition of cancers, today announced the appointment of Joseph Talamo as Chief Financial Officer
What does Intensity Therapeutics do?
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers.
Where is Intensity Therapeutics based?
Intensity Therapeutics is based in Shelton, Connecticut, United States.
Which similar companies made leadership changes around the same time?
HaemaLogiX (November 14, 2023), Century Therapeutics (November 9, 2023), Genentech (November 7, 2023) and CTRL Therapeutics (December 12, 2023) also announced leadership changes within 45 days of Intensity Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Intensity Therapeutics, and when

A new leader at Intensity Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Intensity Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Intensity Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Intensity Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Intensity Therapeutics

Location

Shelton, Connecticut, United States

About

Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Intensity Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Joseph
Likely contact at this company
••••••••@••••••••

See Joseph's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Intensity Therapeutics's next move

Learn about Strategic plan

Intensity Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.